Related Experiment Video
Updated: Mar 30, 2026
04:48
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
7.8K
Persistent docetaxel-induced supravenous erythematous eruption.
Karina de Almeida Pinto Fernandes1, Paulo Antônio Oldani Felix1
1Hospital Naval Marcílio Dias, Rio de Janeiro, RJ, Brazil.
Anais Brasileiros De Dermatologia
|November 13, 2015
Summary
Taxanes, used for cancer treatment, can cause skin toxicity. However, these reactions to docetaxel often do not require treatment interruption.
Area of Science:
- Oncology
- Dermatology
Background:
- Taxanes are a class of chemotherapy drugs widely used in treating various cancers, such as breast and lung cancer.
- Common side effects include neutropenia and mucositis.
- Skin toxicity is a frequent adverse event, affecting approximately 65% of patients.
Observation:
- Observed skin reactions to docetaxel encompass alopecia, hypersensitivity, persistent erythematous eruptions, nail changes, and scleroderma-like reactions.
- Two specific cases of docetaxel-induced skin reactions are presented.
Findings:
- Skin reactions to docetaxel are common but may not necessitate treatment cessation.
- Management strategies for taxane-induced dermatologic toxicities are crucial for patient care.
Implications:
- This highlights the importance of recognizing and managing skin toxicities associated with docetaxel.
- Continued taxane therapy may be feasible despite certain skin reactions, improving treatment adherence and outcomes.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
135
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
135
01:01Hypersensitivity Reactions: Cytolytic Reactions
127
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
127
01:16Drug toxicity: Idiosyncratic Reactions
168
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
168
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
818
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
818
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
748
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
748
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K